BLGO Share Price Performance
US$0.091
-0.11 (-54.09%)
73.9% undervalued intrinsic discount
US$0.35
Fair Value
Price US$0.091
AnalystConsensusTarget US$0.35
Fair ValueUS$0.35
Share Pricen/a
New Narrative • Apr 08
BioLargo, Inc. Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
BLGO Community Narratives
AN
Fair Value
·Fair Value US$0.35 73.9% undervalued intrinsic discount
PFAS, Battery Tech And Medical Launches Will Shape Markets
1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
BioLargo
73.9% undervalued intrinsic discount
PFAS, Battery Tech And Medical Launches Will Shape Markets
View narrativeAN
Updated 1 May 2025
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
PFAS, Battery Tech And Medical Launches Will Shape Markets
Fair Value: US$0.35 73.9% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
BioLargo, Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -0.044
- 39.91%
- -354.88%
- -187.0%
About BLGO
- Founded
- n/a
- Employees
- 45
- CEO
- WebsiteView website
BioLargo, Inc. invents, develops, and commercializes various platform technologies in the United States. The company’s technologies solve challenging environmental problems comprising per- and polyfluoroalkyl substances (PFAS) water contamination; advanced water and wastewater treatment; industrial odor and volatile organic compounds control, air quality control, and infection control; and myriad environmental remediation. It provides full-service environmental engineering, battery energy storage, and advanced antimicrobial medical device platforms. BioLargo, Inc. is based in Westminster, California.
